Home About Us Writing a Scientific Article Author's Instruction Contact us
 
MERIT RESEARCH JOURNAL OF MEDICINE AND MEDICAL SCIENCES (MRJMMS) (ISSN: 2354-323X)  
 

/  /    MRJMMS Home   /   /    About MRJMMS    /  /    Submit Manuscripts    /  /      Call For Articles      / /     Editorial Board     / /    Archive     / /    Author's Guide  /  /

 
 

September 2022 Vol. 10 No.9
 

Other viewing option


Abstract
• Full text
Reprint (PDF) (101 KB)


Search Pubmed for articles by:
 

Marques GE
dos Santos IF

Other links:
PubMed Citation
Related articles in PubMed

 

Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 10(9) pp. 224-228, September, 2022 

Copyright © 2022 Author(s) retain the copyright of this article
DOI: 10.5281/zenodo.7118456

Review

Medication-Related Osteonecrosis of the Jaw: A Literature Review

 
 
 

Geovana Esteves Marques1*, Eduardo O.C. Farias2, Thiago Quirino Mota da Silva3, Túlio Garcia Margute4, Paulo Fernando Alves4, Tiago Garcia Margute5, Andrei Rabenschlag Rossato6, Vinicius Delatorre7, Igor Fonseca dos Santos8

 

1CEULP-ULBRA, Palmas, TO,Brazil
2Department of Oral and Maxillofacial Surgery, School of Dentistry, UNISUL-SC,, Brazil
3Department of Implantology, CEUMA, MA, São Luis, Brazil.
4Department of Phrostodontics, FACOP, SP, Bauru, Brazil.
5Department of Implantology, FACOP, SP, Bauru. Department of Medicine and Dentistry.
6Department of Implantology, São Leopoldo Mandic, SP, Campinas, Brazil.
7CEULP-ULBRA, Palmas, TO, Brazil
8UNIRG, Paraíso do Tocantins, CEULP-ULBRA, IOA, Palmas-TO, Brazil.

*Corresponding Author's E-mail: tiagomargute@hotmail.com

Received: 25August 2022  I  Accepted: 26 September 2022  I  Published: 28 September 2022  I  Article ID: MRJMMS22064
Copyright © 2022 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.

 

Abstract

 

Medication-related osteonecrosis of the jaw is a recent pathology, initially mentioned in 2003 by Marx, but associated only with the bisphosphonates. In 2011, other studies showed that drugs from other groups of medication were also responsible for developing the disease. Currently, antiresorptive and angiogenic drugs are correlated as risk factors for osteonecrosis of the jaws, but there are other risk factors, such as smoking, alcohol intake, drug use for more than three years, obesity, treatments with use of corticosteroids and chemotherapy drugs. The associated local factors are linked to surgical procedures such as extractions and dental implants, due to the inflammatory process generated at the spot. The disease has several stages, and may be symptomatic or asymptomatic, depending on the stages. In its clinical characteristics, it can demonstrate the presence of necrotic bone exposed in the oral cavity with or without the presence of intraoral or extraoral fistula. Treatment consists of proservation and postponing surgical procedures as much as possible, with endodontic or periodontal treatment being the best conduct. Methodology: the present study qualifies as a literature review having the “Pubmed” database as a source of bibliographic research, using keywords such as “MRONJ”, “Osteonecrosis”, “Antiresorptive”, “Antiangiogenic”, among others. It was concluded that there are few studies on this topic, but currently studies point to two groups of drugs as risk factors for the development of the disease, in addition to local and systemic factors.

Keywords: Antiangiogenic, Antiresorptives, Biphosphonates, Osteonecrosis









 

 
 
   
   
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
   
 
                         

Merit Research Journals© 2022 || Advertisement | Privacy policy.